N-5984, a β3-adrenergicreceptoragonist, is used potentially for the treatment of obesity, overactive bladder and type 2 diabetes.This compound is unstable in powder form and other related salt forms are recommended.
Ritobegron (KUC-7483), an effective and selective β3-adrenergicreceptoragonist, shows effective β(3)-AR agonist activity on transfected human β-AR and has an effect on the bladder of rats Shows high selectivity with other organs.